Below you'll find a list of all posts that have been tagged as “Value Stocks”
Highlights: August offered Vailshire Partners LP hedge fund investors exceptionally pleasing results, with monthly returns (net of all fees) of 8.1%. Year-to-date net returns through August 31, 2018 are 14.7%, easily topping our S&P 500 benchmark. The #FAANGs are generally holding up well, and we continue to benefit from our long positions in each of these technology powerhouse companies, save one: …
Highlights: Innovative technology and healthcare companies led the charge last week. Moderate position turnover occurred in Vailshire Partners, LP during the week of August 20-24. The fund continues to handily outperform the S&P 500 in 2018. New LONG position(s) in Vailshire Partners, LP last week: $CRM $ESPR long-dated calls $ELY Closed LONG position(s): None. New SHORT position(s): $TIVO $FTR $XPP $F Covered …
It was an exceptionally busy week of trading last week at Vailshire. Our fund remains well-positioned for a strong future performance… whatever comes our way. New LONG position(s) in Vailhsire Partners, LP last week: $ADSK $BP $CDMO $CGC $MKL $TEVA $TEAM $GSM $CBRL Closed LONG position(s): $BKNG $BIDU $NPSNY $SAND $TSG New SHORT position(s): None. Covered SHORT position(s): $BMY $ED Gross August …
New LONG position(s) in Vailhsire Partners, LP last week: $UNH $TREX $SFIX $BDX Closed LONG position(s): $IPGP $IQ New SHORT position(s): $COK $FM Covered SHORT position(s): $XLP $BXP $CELG Net July 2018 returns (through 7/31/18): 0.5% Net YTD returns (through 7/31/18): 6.2% ———- Check out Jeff’s recently published investment advisory article on Seeking Alpha, entitled: The Pullback is Overdone. Abiomed is Now a Strong Buy …
